Found: 32
Select item for more details and to access through your institution.
Identification of secondary structure in the 5′-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translation.
- Published in:
- Oncogene, 2006, v. 25, n. 49, p. 6510, doi. 10.1038/sj.onc.1209672
- By:
- Publication type:
- Article
(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Glioblastomes: aspects moléculaires et prise en charge actuelle.
- Published in:
- Oncologie (Tech Science Press), 2009, v. 11, n. 2, p. 67, doi. 10.1007/s10269-008-1037-6
- By:
- Publication type:
- Article
P11.04 Autonomy duration as analyzed by KPS≥70 cumulative time in patients with biopsy-only glioblastoma (BO-GBM). A sub-analysis of the Timone cohort.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii29, doi. 10.1093/neuonc/noab180.100
- By:
- Publication type:
- Article
P04.08 Biopsy-only glioblastoma (BO-GBM) as a heterogeneous group of patients.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii20, doi. 10.1093/neuonc/noab180.065
- By:
- Publication type:
- Article
KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma (OLAGLI).
- Published in:
- 2021
- By:
- Publication type:
- Abstract
PL03.4.A Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii2, doi. 10.1093/neuonc/noab180.006
- By:
- Publication type:
- Article
PL03.1.A Surgery for glioblastomas in the elderly: an ANOCEF trial (CSA).
- Published in:
- 2021
- By:
- Publication type:
- Abstract
P14.73 Toxicity and outcomes of reduced-dose whole brain radiotherapy as consolidation treatment for patients with CNS lymphoma in real life setting.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii84, doi. 10.1093/neuonc/noz126.308
- By:
- Publication type:
- Article
P14.33 Adult brainstem gliomas in neurofibromatosis type 1 (NF1).
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii74, doi. 10.1093/neuonc/noz126.268
- By:
- Publication type:
- Article
P13.09 Genomic analysis of paired IDHwt glioblastoma (GB) reveals recurrent alterations of MPDZ at relapse after radiotherapy and temozolomide (RTCT).
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii64, doi. 10.1093/neuonc/noz126.230
- By:
- Publication type:
- Article
OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii16, doi. 10.1093/neuonc/noz126.055
- By:
- Publication type:
- Article
OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM).
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii14, doi. 10.1093/neuonc/noz126.047
- By:
- Publication type:
- Article
OS7.2 Measuring change in health-related quality of life: the added value of analysis on the individual patient level in glioma patients in clinical decision making.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii14, doi. 10.1093/neuonc/noz126.045
- By:
- Publication type:
- Article
OS4.1 MEVITEM: A European, randomized, open-label, Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or refractory medulloblastoma presenting an activation of the Sonic Hedgehog (SHH) pathway
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii10, doi. 10.1093/neuonc/noz126.031
- By:
- Publication type:
- Article
OS1.7 Plasmatic differential scanning fluorimetry profiles discriminate glioma patients from healthy controls.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii7, doi. 10.1093/neuonc/noz126.020
- By:
- Publication type:
- Article
P01.041 Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii238, doi. 10.1093/neuonc/noy139.083
- By:
- Publication type:
- Article
P01.032 Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii235, doi. 10.1093/neuonc/noy139.074
- By:
- Publication type:
- Article
OS2.4 Angiotensin II Receptor Blockers, steroids and radiotherapy in glioblastoma - A randomized multicenter trial (ASTER Trial). An ANOCEF Study.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii219, doi. 10.1093/neuonc/noy139.017
- By:
- Publication type:
- Article
P17.20 PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii91, doi. 10.1093/neuonc/nou174.350
- By:
- Publication type:
- Article
P04.08 PLASMA LEVELS AND TUMOR TISSUE RNA OF MMP2 AND MMP9 EXHIBIT SIMILAR DISTRIBUTION IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA (GB).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii38, doi. 10.1093/neuonc/nou174.140
- By:
- Publication type:
- Article
P04.07 EXPRESSION PROFILE OF ANGIOGENIC FACTORS IN PAIRED INITIAL AND RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii38, doi. 10.1093/neuonc/nou174.139
- By:
- Publication type:
- Article
IDH mutation is paradoxically associated with higher F-FDOPA PET uptake in diffuse grade II and grade III gliomas.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 8, p. 1306, doi. 10.1007/s00259-017-3668-6
- By:
- Publication type:
- Article
The role of Gamma Knife radiosurgery in the treatment of pineal parenchymal tumours.
- Published in:
- Acta Neurochirurgica, 2006, v. 148, n. 1, p. 5, doi. 10.1007/s00701-005-0626-z
- By:
- Publication type:
- Article
Prognostic impact of O(6)-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 155, doi. 10.1007/s11060-016-2161-6
- By:
- Publication type:
- Article
Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 127, n. 1, p. 111, doi. 10.1007/s11060-015-2015-7
- By:
- Publication type:
- Article
Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 114, n. 2, p. 191, doi. 10.1007/s11060-013-1170-y
- By:
- Publication type:
- Article
Pineal Region Tumors: The Role of Stereotactic Radiosurgery.
- Published in:
- Stereotactic & Functional Neurosurgery, 1996, v. 66, n. S1, p. 164, doi. 10.1159/000099807
- By:
- Publication type:
- Article
Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002).
- Published in:
- British Journal of Cancer, 2003, v. 89, p. S73, doi. 10.1038/sj.bjc.6601087
- By:
- Publication type:
- Article
Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas.
- Published in:
- 2003
- By:
- Publication type:
- journal article
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 4, p. 334, doi. 10.1007/s12325-011-0007-3
- By:
- Publication type:
- Article